Original articleDesign, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives
-
Add time:08/29/2019 Source:sciencedirect.com
The analogs of N-[4-(piperazin-1-yl)phenyl]cinnamamide were designed and synthesized by molecular hybridization approach in which part C of the designed molecule was linked through amide and carbamate functionality that improves the physicochemical properties and govern the pharmacokinetic and pharmacodynamic behavior. The systematic modification was done around the Part C to explore the structure activity relationship of antitubercular cinnamamide. All 52 compounds were evaluated for its antitubercular activity against Mycobacterium tuberculosis (M. tb) using Resazurin microtitre plate assay (REMA). Compound 11g with trifluoromethyl substitution exhibited good antitubercular activity of 3.125 μg/ml. The synthesized N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives showed promising activity against M. tb.
We also recommend Trading Suppliers and Manufacturers of 6-Fluoro-7-(piperazin-1-yl)-9-cyclopropylisothiazolo[5,4-b]quinoline-3,4(2H,9H)-dione (cas 111279-87-9). Pls Click Website Link as below: cas 111279-87-9 suppliers
Prev:Does Size Really Matter? Probing the Efficacy of Structural Reduction in the Optimization of Bioderived Compounds – A Computational “Proof-of-Concept”
Next:Preliminary communicationSynthesis, computational studies and preliminary pharmacological evaluation of 2–[4-(aryl substituted) piperazin-1-yl] N, N-diphenylacetamides as potential antipsychotics) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research paperSynthesis and pharmacological characterization of novel N-(trans-4-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)cyclohexyl)amides as potential multireceptor atypical antipsychotics09/01/2019
- 7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: Synthesis and in vitro biological evaluation as potential antitumor agents08/31/2019
- Preliminary communicationSynthesis, computational studies and preliminary pharmacological evaluation of 2–[4-(aryl substituted) piperazin-1-yl] N, N-diphenylacetamides as potential antipsychotics08/30/2019


